NASDAQ hot!!!, page-716

As we enjoy a very green day, on red ASX day and await the FDA decision, I was reviewing the time of the 9 to 1 ODAC vote and looking at the roller coaster share price prior and immediately after (as this may provide an indication as to what to expect if successful).

I'm sure there are many LTSH's would vividly remember what was an exceptionally long and nerve racking night.

In my street (as there were may MSB holders) the tension was palpable.

By the morning of Thursday the 14th August 2020 (I had no finger nails left).

I think those few minutes waiting for the votes to be counted would rate as the most nerve racking of my life.

That euphoric feeling (as they initial read out 8 to 2 and subsequently changed it to 9 to1).

Below I have shown the few days before and after ODAC from a trading perspective (perhaps to gain an idea of what we may be in for).

Obviously due to the dilution in the last four years the share price and volumes are different .

I only hope that we all get to experience the euphoria again (with in the next few months), that I felt when they announced the vote, which then followed by this headline:

U.S. FDA ADVISORY COMMITTEE VOTES NINE TO ONE IN FAVOR OF REMESTEMCEL-L (RYONCIL™) FOR EFFICACY IN CHILDREN WITH STEROIDREFRACTORY ACUTE GRAFT VERSUS HOST DISEASE